VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+2.93%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$182M
AUM Growth
+$182M
(-5.1%)
Cap. Flow
-$9.35M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
6.2%
Holding
508
New
65
Increased
160
Reduced
215
Closed
68
Top Buys
| 1 |
Dow Inc
DOW
|
$1.16M |
| 2 |
Hershey
HSY
|
$1.04M |
| 3 |
Copart
CPRT
|
$1.03M |
| 4 |
lululemon athletica
LULU
|
$1.02M |
| 5 |
Progressive
PGR
|
$999K |
Top Sells
| 1 |
Lennar Class A
LEN
|
$952K |
| 2 |
TJX Companies
TJX
|
$909K |
| 3 |
Ameriprise Financial
AMP
|
$902K |
| 4 |
Abbott
ABT
|
$892K |
| 5 |
Home Depot
HD
|
$885K |
Sector Composition
| 1 | Healthcare | 25.65% |
| 2 | Financials | 14.09% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.21% |
| 5 | Materials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
4D Molecular Therapeutics
FDMT
$287M
| $71.2K | 0.04% |
4,140
-1,591
| -28% | -$27.3K |
|
402
Editas Medicine
EDIT
$222M
| $70.8K | 0.04% |
9,769
-3,751
| -28% | -$27.2K |
|
|
IGMS
403
DELISTED
IGM Biosciences
IGMS
| $70.3K | 0.04% |
5,113
-1,965
| -28% | -$27K |
|
404
Invesco Senior Income Trust
VVR
$556M
| $69K | 0.04% |
18,740
-57,421
| -75% | -$211K |
|
405
Lyell Immunopharma
LYEL
$219M
| $67.1K | 0.04% |
28,421
-10,924
| -28% | -$25.8K |
|
406
Repare Therapeutics
RPTX
$73M
| $67K | 0.04% |
6,808
-2,618
| -28% | -$25.8K |
|
407
Arcutis Biotherapeutics
ARQT
$1.84B
| $67K | 0.04% |
6,088
-2,335
| -28% | -$25.7K |
|
|
BCYC
408
Bicycle Therapeutics
BCYC
$499M
| $66.9K | 0.04% |
3,145
-1,216
| -28% | -$25.9K |
|
409
Alector
ALEC
$262M
| $66.7K | 0.04% |
10,782
-4,151
| -28% | -$25.7K |
|
410
Caribou Biosciences
CRBU
$175M
| $65.8K | 0.04% |
12,399
-4,766
| -28% | -$25.3K |
|
411
Design Therapeutics
DSGN
$326M
| $65.8K | 0.04% |
11,396
-4,378
| -28% | -$25.3K |
|
412
iTeos Therapeutics
ITOS
| $65.1K | 0.04% |
4,782
-1,838
| -28% | -$25K |
|
|
INBX
413
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $64.9K | 0.04% |
3,438
-1,323
| -28% | -$25K |
|
414
Allogene Therapeutics
ALLO
$249M
| $64.6K | 0.04% |
13,071
-5,026
| -28% | -$24.8K |
|
|
VERV
415
DELISTED
Verve Therapeutics
VERV
| $64.5K | 0.04% |
4,471
-1,724
| -28% | -$24.9K |
|
|
ALLK
416
DELISTED
Allakos
ALLK
| $64.2K | 0.04% |
14,435
-5,546
| -28% | -$24.7K |
|
417
Replimune Group
REPL
$461M
| $64K | 0.04% |
3,623
-1,396
| -28% | -$24.7K |
|
|
AFMD
418
DELISTED
Affimed
AFMD
| $63.9K | 0.04% |
85,752
-32,951
| -28% | -$24.6K |
|
419
Erasca
ERAS
$454M
| $62.9K | 0.03% |
20,902
-8,038
| -28% | -$24.2K |
|
420
Precigen
PGEN
$1.42B
| $62.7K | 0.03% |
59,170
-22,742
| -28% | -$24.1K |
|
421
Day One Biopharmaceuticals
DAWN
$758M
| $62.6K | 0.03% |
4,685
-1,797
| -28% | -$24K |
|
|
KLRS
422
Kalaris Therapeutics, Inc. Common Stock
KLRS
$74.8M
| $59.5K | 0.03% |
15,096
-5,810
| -28% | -$22.9K |
|
423
ATAI Life Sciences
ATAI
$984M
| $59.1K | 0.03% |
32,639
-12,545
| -28% | -$22.7K |
|
424
Mersana Therapeutics
MRSN
$35M
| $58.2K | 0.03% |
14,172
-5,446
| -28% | -$22.4K |
|
|
AGEN
425
Agenus
AGEN
$133M
| $57.2K | 0.03% |
37,616
-14,454
| -28% | -$22K |
|